Magnetic Resonance Imaging and Positron-Emission Tomography Imaging in the 21st Century as Tools for the Evaluation and Management of Patients With Invasive Cervical Carcinoma

Seminars in Radiation Oncology

Volumn 16, Issue 3, 2006, Pages 186-191

  Wolfson, Aaron H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; IRON OXIDE; ULTRASMALL PARTICLE OF IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; BRACHYTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE DISTRIBUTION; RADIODIAGNOSIS; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; X RAY;

DIAGNOSTIC IMAGING; FEMALE; HISTORY, 21ST CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; UTERINE CERVICAL NEOPLASMS;

EID: 33745269201     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.02.008     Document Type: Article

References (29)

1. Whitney C.W., Sause W., Bundy B.N., et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
2. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compare with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
3. Rose P.G., Bundy B.N., Watkins J., et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
4. FIGO. International Federation of Gynecology and Obstetrics: Classification and staging of malignant tumors in the female pelvis: Annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 28 (1989) 189
5. League of Nations Health Organization. Inquiry Into the Results of Radiotherapy in Cancer of the Uterus. Atlas Illustrating the Division of Cancer of the Uterine Cervix into Four Stages According to the Anatomo-clinical Extern of the Trowth (1938), Norstedt & Soner, Stockholm, Sweden
6. Van Nagell Jr. J.R., Roddick Jr. J.W., and Lowin D.M. The staging of cervical cancer. Inevitable discrepancies between clinical staging and pathologic findings. Am J Obstet Gynecol 110 (1971) 973-978
7. Averette H.E., Ford Jr. J.H., Dudan R.C., et al. Staging of cervical cancer. Clin Obstet Gynecol 18 (1975) 215-232
8. Lagasse L.D., Creasman W.T., Shingleton H.M., et al. Results and complications of operative staging in cervical cancer. Experience of the Gynecologic Oncology Group. Gynecol Oncol 9 (1980) 90-98
9. Wagenaar H.C., Trimbos J.B.M.Z., Postema S., et al. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 82 (2001) 474-482
10. Mayr N.A., Taoka T., Yuh W.T., et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 52 (2002) 14-22
11. Mayr N.A., Yuh W.T., Wu D., et al. Microcirculation MR imaging for prediction of long-term outcome in cervical cancer. Proc Am Soc Clin Oncol 23 (2005) 461s (abstr)
12. Rockall A.G., Sohaib S.A., Harisinghani M.G., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 (2005) 2813-2821
13. Smith T. FDG uptake, tumor characteristics, and response to therapy. A review. Nucl Med Commun 19 (1998) 97-105
14. Dizendorf E.V., Baumert B.G., von Schulthess G.K., et al. Impact of whole-body FFDG PET on staging and managing patients for radiation therapy. J Nucl Med 44 (2003) 24-29
15. Grigsby P.W., Siegel B.A., and Dehadashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19 (2001) 3745-3749
16. Grisgby P.W., Siegel B.A., Dehdashti F., et al. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 35 (2003) 907-913
17. Rosenman J. Incorporating functional imaging information into radiation treatment. Semin Radiat Oncol 11 (2001) 83-92
18. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT). A feasibility study. Int J Radiat Oncolo Biol Phys 57 (2003) 853-863
19. Grigsby P.W., Singh A.K., Siegel B.A., et al. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 59 (2004) 706-712
20. Perez C.A., Bradley J., Chao C.K., et al. Functional imaging in treatment planning in radiation therapy. A review. Rays 27 (2002) 157-173
21. Mutic S., Malyapa R.S., Grigsby P.G., et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes. A dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55 (2003) 28-35
22. Esthappan J., Mutic S., Malyapa R.S., et al. Treatment planning guidelines regarding the use of CT/PET guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 58 (2004) 1289-1297
23. Mutic S., Grigsby P.W., Low D.A., et al. PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys 52 (2002) 1104-1110
24. Malyapa R.S., Mutic S., Low D.A., et al. Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1140-1146
25. International Commission on Radiation Units and Measurements (ICRU). ICRU Report 38. Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology (1985), ICRU, Bethesda, MD
26. International Commission on Radiation Units and Measurements (ICRU). ICRU Report 50. Prescribing, Recording, and Reporting Photon Beam Therapy (1993), ICRU, Washington, DC
27. Miller T.R., and Grigsby P.W. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical carcinoma treated by radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 353-359
28. Low D.A., Grigsby P.W., Dempsey J.F., et al. Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 52 (2002) 1400-1406
29. Wahab S., Malyapa R.S., Mutic S., et al. A treatment planning study comparing HDR against AGIMRT for cervical cancer. Med Phys 31 (2004) 734-743